Helius Medical Technologies, Inc. (HSDT)
USD 0.38
(-6.0%)
USD 0.38
(-6.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.12 Million USD | 64.51% |
| 2022 | -14.43 Million USD | -31.24% |
| 2021 | -11 Million USD | -239.57% |
| 2020 | -3.24 Million USD | 32.81% |
| 2019 | -4.82 Million USD | 81.15% |
| 2018 | -25.58 Million USD | -359.96% |
| 2017 | -5.56 Million USD | -108.39% |
| 2016 | -2.66 Million USD | -537.16% |
| 2015 | -418.89 Thousand USD | -4654266.67% |
| 2014 | -9.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -6.35 Million USD | -76.84% |
| 2024 Q1 | -3.59 Million USD | 29.91% |
| 2023 FY | -5.12 Million USD | 64.51% |
| 2023 Q2 | -8.51 Million USD | 24.26% |
| 2023 Q1 | -11.24 Million USD | 22.13% |
| 2023 Q3 | -6.52 Million USD | 23.36% |
| 2023 Q4 | -5.12 Million USD | 21.47% |
| 2022 Q3 | -16.53 Million USD | -426.93% |
| 2022 Q1 | -6.16 Million USD | 44.01% |
| 2022 FY | -14.43 Million USD | -31.24% |
| 2022 Q4 | -14.43 Million USD | 12.68% |
| 2022 Q2 | -3.13 Million USD | 49.06% |
| 2021 Q2 | -7.36 Million USD | 34.96% |
| 2021 Q3 | -4.65 Million USD | 36.81% |
| 2021 Q1 | -11.32 Million USD | -249.38% |
| 2021 FY | -11 Million USD | -239.57% |
| 2021 Q4 | -11 Million USD | -136.45% |
| 2020 FY | -3.24 Million USD | 32.81% |
| 2020 Q1 | -3.76 Million USD | 21.96% |
| 2020 Q2 | -5.04 Million USD | -34.15% |
| 2020 Q4 | -3.24 Million USD | -28.27% |
| 2020 Q3 | -2.52 Million USD | 49.96% |
| 2019 Q2 | -13.6 Million USD | 24.06% |
| 2019 Q1 | -17.91 Million USD | 29.99% |
| 2019 FY | -4.82 Million USD | 81.15% |
| 2019 Q4 | -4.82 Million USD | 42.21% |
| 2019 Q3 | -8.34 Million USD | 38.65% |
| 2018 Q3 | -12.39 Million USD | 22.46% |
| 2018 Q4 | -25.58 Million USD | -106.36% |
| 2018 FY | -25.58 Million USD | -359.96% |
| 2018 Q2 | -15.98 Million USD | -263.75% |
| 2018 Q1 | -4.39 Million USD | 20.98% |
| 2017 Q4 | -5.56 Million USD | -112.53% |
| 2017 FY | -5.56 Million USD | -108.39% |
| 2017 Q3 | -2.61 Million USD | 61.85% |
| 2017 Q2 | -6.85 Million USD | 10.53% |
| 2017 Q1 | -7.66 Million USD | -187.23% |
| 2016 Q2 | -7.77 Million USD | -194.01% |
| 2016 Q1 | -2.64 Million USD | 39.22% |
| 2016 FY | -2.66 Million USD | -537.16% |
| 2016 Q4 | -2.66 Million USD | 56.76% |
| 2016 Q3 | -6.17 Million USD | 20.59% |
| 2015 Q2 | -971.86 Thousand USD | -132.01% |
| 2015 Q1 | -418.89 Thousand USD | 85.59% |
| 2015 Q4 | -4.35 Million USD | -56277.04% |
| 2015 FY | -418.89 Thousand USD | -4654266.67% |
| 2015 Q3 | 7744.00 USD | 100.8% |
| 2014 FY | -9.00 USD | 0.0% |
| 2014 Q3 | -5 Million USD | 28.88% |
| 2014 Q4 | -2.9 Million USD | 41.87% |
| 2014 Q1 | 368.01 Thousand USD | 0.0% |
| 2014 Q2 | -7.03 Million USD | -2010.32% |
| 2013 Q2 | 217.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 118.924% |
| BrainsWay Ltd. | -10.32 Million USD | 50.339% |
| Cerus Corporation | 84.35 Million USD | 106.076% |
| Envoy Medical, Inc. | -3.81 Million USD | -34.373% |
| electroCore, Inc. | -9.95 Million USD | 48.518% |
| IceCure Medical Ltd | -9.93 Million USD | 48.41% |
| Inogen, Inc. | -103.56 Million USD | 95.052% |
| OrthoPediatrics Corp. | -9.26 Million USD | 44.696% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -40.758% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 60.869% |
| MaxCyte, Inc. | -27.76 Million USD | 81.54% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 0.255% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -790.117% |
| Orthofix Medical Inc. | 96.44 Million USD | 105.314% |
| PAVmed Inc | 29.08 Million USD | 117.62% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 69.744% |
| RxSight, Inc. | -6.68 Million USD | 23.278% |
| Sight Sciences, Inc. | -102.71 Million USD | 95.01% |
| SI-BONE, Inc. | 5.72 Million USD | 189.582% |
| TELA Bio, Inc. | -3.94 Million USD | -29.78% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 108.941% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 1555.966% |
| Acutus Medical, Inc. | 12.27 Million USD | 141.738% |
| Talis Biomedical Corporation | -57.06 Million USD | 91.019% |
| Spectral AI, Inc. | -3.5 Million USD | -46.387% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 89.329% |
| CVRx, Inc. | -59.95 Million USD | 91.452% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 358.298% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 501.131% |
| Bioventus Inc. | 372.51 Million USD | 101.376% |
| Venus Concept Inc. | 74.3 Million USD | 106.898% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 49.666% |
| LivaNova PLC | 62.53 Million USD | 108.196% |
| 908 Devices Inc. | -115.09 Million USD | 95.547% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 101.598% |
| Nemaura Medical Inc. | 9.92 Million USD | 151.637% |
| NeuroPace, Inc. | 54.33 Million USD | 109.432% |
| LENSAR, Inc. | -18.31 Million USD | 72.013% |
| Apyx Medical Corporation | -5.15 Million USD | 0.505% |
| Cutera, Inc. | 288.3 Million USD | 101.778% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 168.197% |
| BioSig Technologies, Inc. | 262 Thousand USD | 2056.107% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 88.307% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 44.287% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.365% |
| Axonics, Inc. | -77.19 Million USD | 93.361% |
| Outset Medical, Inc. | 67.67 Million USD | 107.573% |
| IRIDEX Corporation | -4.28 Million USD | -19.52% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 97.121% |
| IRadimed Corporation | -47.71 Million USD | 89.26% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -69.365% |
| INVO Bioscience, Inc. | 8.45 Million USD | 160.643% |
| Telesis Bio, Inc. | 32.63 Million USD | 115.704% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -104.825% |
| Varex Imaging Corporation | 316.9 Million USD | 101.617% |
| Quipt Home Medical Corp. | 81.73 Million USD | 106.27% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -84.22% |
| Pulmonx Corporation | -42.36 Million USD | 87.901% |
| Dynatronics Corporation | 6.2 Million USD | 182.608% |
| Modular Medical, Inc. | -8.04 Million USD | 36.272% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -19.269% |
| Semler Scientific, Inc. | -57.13 Million USD | 91.029% |
| InMode Ltd. | -135.39 Million USD | 96.215% |
| Bruker Corporation | 891.3 Million USD | 100.575% |
| Cytosorbents Corporation | 4.18 Million USD | 222.549% |
| DexCom, Inc. | 2.02 Billion USD | 100.253% |
| Align Technology, Inc. | -840.47 Million USD | 99.39% |
| Viveve Medical, Inc. | -13.81 Million USD | 62.897% |
| ZimVie Inc. | 450.41 Million USD | 101.138% |
| Movano Inc. | -5.86 Million USD | 12.632% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 96.188% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -790.117% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 358.298% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 101.436% |
| Profound Medical Corp. | -18.17 Million USD | 71.807% |
| Insulet Corporation | 798.1 Million USD | 100.642% |
| enVVeno Medical Corporation | -2.21 Million USD | -131.064% |
| Surmodics, Inc. | -12.01 Million USD | 57.341% |
| iCAD, Inc. | -21.2 Million USD | 75.836% |
| Nuwellis, Inc. | -2.81 Million USD | -81.802% |
| Biotricity, Inc. | 23.09 Million USD | 122.193% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 105.472% |
| Aethlon Medical, Inc. | -4.5 Million USD | -13.847% |
| InspireMD, Inc. | -8.04 Million USD | 36.296% |
| PAVmed Inc. | 29.08 Million USD | 117.62% |
| BIOLASE, Inc. | 11.34 Million USD | 145.178% |
| Beyond Air, Inc. | 6.22 Million USD | 182.276% |
| FONAR Corporation | -14.66 Million USD | 65.054% |
| AxoGen, Inc. | 32.26 Million USD | 115.884% |
| Vivani Medical, Inc. | 42 Thousand USD | 12302.381% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 51.914% |
| Inari Medical, Inc. | -7.16 Million USD | 28.432% |
| UFP Technologies, Inc. | 40.77 Million USD | 112.569% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 267.013% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -7.413% |
| Tenon Medical, Inc. | -1.25 Million USD | -308.367% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 32.619% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 57.028% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.231% |
| Sintx Technologies, Inc. | 905 Thousand USD | 666.298% |
| NanoVibronix, Inc. | -3.27 Million USD | -56.345% |
| Quanterix Corporation | -132.95 Million USD | 96.145% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -84.22% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 77.085% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.68% |
| TransMedics Group, Inc. | 121.13 Million USD | 104.231% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 80.424% |
| NeuroMetrix, Inc. | -1.49 Million USD | -243.713% |
| Hyperfine, Inc. | -75.61 Million USD | 93.223% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 103.368% |
| Biomerica, Inc. | -3.38 Million USD | -51.403% |
| Bone Biologics Corporation | -3.02 Million USD | -69.334% |
| AVITA Medical, Inc. | -26.23 Million USD | 80.463% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -178.773% |
| Silk Road Medical, Inc | 64.42 Million USD | 107.955% |